November 2021 – STERIS is pleased to announce that it has been accepted to participate in the U.S. Food and Drug Administration (FDA) Ethylene Oxide Sterilization Master File Pilot Program (Pilot Program), first announced by the FDA in 2019.
Details
November 2021 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the expansion of its existing Brooklyn Park, Minnesota, USA laboratory to include product and packaging testing services.
Details
September 2021 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Venlo, The Netherlands facility has now received its updated ISO 13485 accreditation to include X-ray processing.
Details
March 2021 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Libertyville, Illinois, USA laboratory is now ISO 17025 accredited.
Details
December 2020 – Following the addition of electron beam testing services at our Radiation Technology Center (RTC) in Libertyville, Illinois, USA, STERIS is pleased to announce the addition of X-ray testing services, completing the expansion of this dedicated facility.
Details
December 2020 – STERIS is pleased to announce the completed expansion of its existing Bradford, UK gamma processing site to include a dedicated Radiation Technology Centre (RTC), specializing in the processing of non-routine samples.
Details